Acinetobacter baumannii (DSM 101993, RUH 2037)
Acinetobacter baumannii DSM 101993 is a bacterium that has multiple antibiotic resistances.
antibiotic resistance genome sequence BacteriaName and taxonomic classification
| @ref 20215 |
Last LPSN update
2026-05-29 08:43:51 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Moraxellaceae |
| Genus Acinetobacter |
| Species Acinetobacter baumannii |
| Full scientific name Acinetobacter baumannii Bouvet and Grimont 1986 |
Culture and growth conditions
Culture medium
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 64488 | LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) | Medium recipe at MediaDive  | Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water |
Culture temp
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 64488 | positive | growth | 37 |
Physiology and metabolism
Oxygen tolerance
| @ref | Oxygen tolerance | Confidence | |
|---|---|---|---|
| 125439 | obligate aerobe | 99.832 |
Antibiotic susceptibility testing
| Test 1 | |
|---|---|
| @ref | 64488 |
| Medium | Mueller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 20 |
| Ampicillin 10µg (disc) | 0 |
| Aztreonam 30µg (disc) | 0 |
| Bacitracin 10Unit | 0 |
| Cefalotin 30µg (disc) | 0 |
| Cefazolin 30µg (disc) | 0 |
| Cefotaxime 30µg (disc) | 0 |
| Ceftriaxone 30µg (disc) | 6 |
| Chloramphenicol 30µg (disc) | 0 |
| Clindamycin 10µg (disc) | 0 |
| Colistin 10µg (disc) | 14-16 |
| Doxycycline 30µg (disc) | 12 |
| Erythromycin 15µg (disc) | 10 |
| Fosfomycin 50µg (disc) | 8 |
| Gentamicin 10µg (disc) | 6 |
| Imipenem 10µg (disc) | 34-36 |
| Kanamycin 30µg (disc) | 0 |
| Lincomycin 15µg (disc) | 0 |
| Linezolid 10µg (disc) | 0 |
| Mezlocillin 30µg (disc) | 0 |
| Moxifloxacin 5µg (disc) | 6-8 |
| Neomycin 30µg (disc) | 8-10 |
| Nitrofurantoin 100µg (disc) | 0 |
| Norfloxacin 10µg (disc) | 0 |
| Nystatin 100Unit | 0 |
| Ofloxacin 5µg (disc) | 0 |
| Oxacillin 5µg (disc) | 0 |
| Penicillin G 6µg (disc) | 0 |
| Pipemidic acid 20µg (disc) | 0 |
| Piperacillin/Tazobactam 40µg (disc) | 12 |
| Polymyxin B 300Unit | 16-18 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 |
| Teicoplanin 30µg (disc) | 0 |
| Tetracycline 30µg (disc) | 0 |
| Ticarcillin 75µg (disc) | 0 |
| Vancomycin 30µg (disc) | 0 |
Spore formation
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 97.643 |
Antibiotic resistance
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 64488 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 64488 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 64488 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 64488 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 64488 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 64488 | 204928 | Cefotaxime | 30 µg (disc) | from Antibiotic test | |
| 64488 | 17698 | Chloramphenicol | 30 µg (disc) | from Antibiotic test | |
| 64488 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 64488 | 6104 | Kanamycin | 30 µg (disc) | from Antibiotic test | |
| 64488 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 64488 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 64488 | 6919 | Mezlocillin | 30 µg (disc) | from Antibiotic test | |
| 64488 | 71415 | Nitrofurantoin | 100 µg (disc) | from Antibiotic test | |
| 64488 | 100246 | Norfloxacin | 10 µg (disc) | from Antibiotic test | |
| 64488 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 64488 | 7731 | Ofloxacin | 5 µg (disc) | from Antibiotic test | |
| 64488 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 64488 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 64488 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 64488 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 64488 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 64488 | 27902 | Tetracycline | 30 µg (disc) | from Antibiotic test | |
| 64488 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 64488 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
Interaction and safety
Risk assessment
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 64488 | 2 | Risk group (German classification) |
Phages
| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Acinetobacter phage vB_AbaM-Bhz12 | DSM 101993 | |
| 124042 | Acinetobacter phage vB_AbaM-Bhz23 | DSM 101993 |
Sequence information
Genome sequences
| @ref | Description | Assembly level | INSDC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|
| 124043 | ASM4506449v1 assembly for Acinetobacter baumannii DSM 101993 | contig | GCA_045064495   | 470 | 74.52 | |
Genome browser: GCA_045064495
Literature
Literature 
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review Fagoterapia para infecciones respiratorias bacterianas de adquisición nosocomial: revisión de la literatura | Munoz-Egea M, Rodriguez A, Esteban J, Garcia-Quintanilla M. | Open Respir Arch | 2025 | | ||
| Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages. | Baginska N, Harhala MA, Cieslik M, Orwat F, Weber-Dabrowska B, Dabrowska K, Gorski A, Jonczyk-Matysiak E. | Viruses | 10.3390/v15010231 | 2023 | | |
| The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections. | Garcia-Patino MG, Garcia-Contreras R, Licona-Limon P. | Front Immunol | 10.3389/fimmu.2017.00441 | 2017 | | |
| Metabolism | Modulating Isoprenoid Biosynthesis Increases Lipooligosaccharides and Restores Acinetobacter baumannii Resistance to Host and Antibiotic Stress. | Palmer LD, Minor KE, Mettlach JA, Rivera ES, Boyd KL, Caprioli RM, Spraggins JM, Dalebroux ZD, Skaar EP. | Cell Rep | 10.1016/j.celrep.2020.108129 | 2020 | |
| Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria. | Osman AH, Darkwah S, Kotey FCN, Asante-Poku A, Donkor ES. | Ther Adv Infect Dis | 10.1177/20499361251356057 | 2025 | | |
| Pathogenicity | Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. | Goic-Barisic I, Bedenic B, Tonkic M, Novak A, Katic S, Kalenic S, Punda-Polic V, Towner KJ. | J Clin Microbiol | 10.1128/jcm.02394-08 | 2009 | |
| Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. | Krizova L, Dijkshoorn L, Nemec A. | Antimicrob Agents Chemother | 10.1128/aac.00221-11 | 2011 | | |
| Pathogenicity | Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. | Dietert K, Gutbier B, Wienhold SM, Reppe K, Jiang X, Yao L, Chaput C, Naujoks J, Brack M, Kupke A, Peteranderl C, Becker S, von Lachner C, Baal N, Slevogt H, Hocke AC, Witzenrath M, Opitz B, Herold S, Hackstein H, Sander LE, Suttorp N, Gruber AD. | PLoS One | 10.1371/journal.pone.0188251 | 2017 | |
| Phylogeny | Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii. | Huys G, Huys G, Cnockaert M, Nemec A, Swings J. | J Clin Microbiol | 10.1128/jcm.43.10.5327-5331.2005 | 2005 | |
| Phylogeny | O-antigen diversity among Acinetobacter baumannii strains from the Czech Republic and Northwestern Europe, as determined by lipopolysaccharide-specific monoclonal antibodies. | Pantophlet R, Nemec A, Brade L, Brade H, Dijkshoorn L. | J Clin Microbiol | 10.1128/jcm.39.7.2576-2580.2001 | 2001 | |
| Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. | Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. | Clin Microbiol Rev | 10.1128/cmr.00058-16 | 2017 | | |
| The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. | Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. | PLoS One | 10.1371/journal.pone.0010034 | 2010 | | |
| Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. | Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann ME, Garaizar J, Ursing J, Pitt TL. | J Clin Microbiol | 10.1128/jcm.34.6.1519-1525.1996 | 1996 | | |
| Pathogenicity | Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection. | Wienhold SM, Brack MC, Nouailles G, Krishnamoorthy G, Korf IHE, Seitz C, Wienecke S, Dietert K, Gurtner C, Kershaw O, Gruber AD, Ross A, Ziehr H, Rohde M, Neudecker J, Lienau J, Suttorp N, Hippenstiel S, Hocke AC, Rohde C, Witzenrath M | Viruses | 10.3390/v14010033 | 2021 | |
How to cite
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive157916.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain dataIsabel Schober, Julia Koblitz, Joaquim Sardà Carbasse, Christian Ebeling, Marvin Leon Schmidt, Adam Podstawka, Rohit Gupta, Vinodh Ilangovan, Javad Chamanara, Jörg Overmann, Lorenz Christian Reimer
Nucleic Acids Research; database issue 2025.
License